EQUITY RESEARCH MEMO

Pharmapack Stade

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Pharmapack Stade GmbH is a German contract packaging organization specializing in blistering and secondary packaging for pharmaceutical, nutraceutical, and medical device products. Founded in 1990 and headquartered in Stade, Germany, the company offers flexible packaging solutions for tablets, capsules, and dragees, serving clients ranging from small batches to large-scale production. With a focus on high-quality and customer-specific needs, Pharmapack Stade has established a reputation for reliability in the pharmaceutical supply chain. The company remains privately held and does not disclose financials, but its long-standing presence in the market suggests steady operations. As a contract packaging organization, Pharmapack Stade is positioned to benefit from increasing outsourcing trends in the pharmaceutical industry, particularly in Europe, where demand for specialized packaging services is growing due to stringent regulatory requirements and the need for efficient supply chains. The company's ability to handle diverse product types and batch sizes makes it a versatile partner for both small biotechs and large pharma companies. However, limited public information hinders a comprehensive assessment of its financial health and competitive positioning.

Upcoming Catalysts (preview)

  • 2026Expansion of packaging capacity or facility upgrade45% success
  • TBDNew long-term contract with a major pharmaceutical client35% success
  • 2026Certification for new packaging technologies (e.g., serialization or cold chain)40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)